Lv01
0 积分 2021-08-18 加入
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
6小时前
已完结
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
6小时前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
14天前
已完结
GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma
22天前
已完结
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
22天前
已完结
Interferon-γ: an overview of signals, mechanisms and functions
22天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
27天前
已完结
[Expert consensus on Claudin18.2 expression testing in gastric cancer (2025 version)]
27天前
已完结
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development
1个月前
已完结
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
1个月前
已完结
皖公网安备34019202002308
